{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:27Z","timestamp":1791478347877,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02569-5","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:38:19Z","timestamp":1784083099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-18 Promotes the Development of Lupus Nephritis by Activating the Wnt\/\u03b2-Catenin Signaling Pathway in Renal Tubular Epithelial Cells"],"prefix":"10.1007","volume":"49","author":[{"given":"Jiashun","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"1","key":"2569_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders, H.J., R. Saxena, M.H. Zhao, I. Parodis, J.E. Salmon, and C. Mohan. 2020. Lupus nephritis. Nature Reviews Disease Primers 6 (1): 7. https:\/\/doi.org\/10.1038\/s41572-019-0141-9.","journal-title":"Nature Reviews Disease Primers"},{"issue":"10","key":"2569_CR2","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"XY Zhao","year":"2023","unstructured":"Zhao, X. Y., S. S. Li, Y. X. He, L. J. Yan, F. Lv, and Q. M. Liang et al. 2023. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Annals Of The Rheumatic Diseases 82(10):1328\u20131340.","journal-title":"Annals Of The Rheumatic Diseases"},{"issue":"10","key":"2569_CR3","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1681\/ASN.2016040415","volume":"27","author":"SV Parikh","year":"2016","unstructured":"Parikh, S. V., and B. H. Rovin. 2016. Current and Emerging Therapies for Lupus Nephritis. Journal Of The American Society Of Nephrology 27(10):2929\u20132939.","journal-title":"Journal Of The American Society Of Nephrology"},{"issue":"8","key":"2569_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41581-023-00722-z","volume":"19","author":"C Mohan","year":"2023","unstructured":"Mohan, C., T. Zhang, and C. Putterman. 2023. Pathogenic cellular and molecular mediators in lupus nephritis. Nature Reviews Nephrology 19(8):491\u2013508.","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"2569_CR5","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1038\/s41467-024-47691-w","volume":"15","author":"J Tchen","year":"2024","unstructured":"Tchen, J., Q. Simon, L. Chapart, M. K. Thaminy, S. Vibhushan, and L. Saveanu et al. 2024. PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus. Nature Communications 15(1):3389.","journal-title":"Nature Communications"},{"key":"2569_CR6","doi-asserted-by":"publisher","first-page":"676082","DOI":"10.3389\/fimmu.2021.676082","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding, X., Y. Ren, and X. He. 2021. IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis. Frontiers in immunology 12:676082.","journal-title":"Frontiers in immunology"},{"issue":"1","key":"2569_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","volume":"21","author":"V Oke","year":"2019","unstructured":"Oke, V., I. Gunnarsson, J. Dorschner, S. Eketj\u00e4ll, A. Zickert, and T. B. Niewold et al. 2019. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Res Ther 21(1):107.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2569_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","volume":"17","author":"F Chasset","year":"2018","unstructured":"Chasset, F., and L. Arnaud. 2018. Targeting interferons and their pathways in systemic lupus erythematosus. Autoimmunity Reviews 17 (1): 44\u201352.","journal-title":"Autoimmunity Reviews"},{"issue":"7","key":"2569_CR9","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.4049\/jimmunol.170.7.3915","volume":"170","author":"E Kikawada","year":"2003","unstructured":"Kikawada, E., D. M. Lenda, and V. R. Kelley. 2003. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. The Journal Of Immunology 170(7):3915\u20133925.","journal-title":"The Journal Of Immunology"},{"key":"2569_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4927530","author":"KR Sigdel","year":"2016","unstructured":"Sigdel, K.R., L. Duan, Y. Wang, W. Hu, N. Wang, Q. Sun, et al. 2016. Serum cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: From a Southern Chinese Han population. Mediators of Inflammation. https:\/\/doi.org\/10.1155\/2016\/4927530.","journal-title":"Mediators of Inflammation"},{"issue":"9","key":"2569_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech, M., and H. J. Anders. 2013. The pathogenesis of lupus nephritis. Journal Of The American Society Of Nephrology 24(9):1357\u20131366.","journal-title":"Journal Of The American Society Of Nephrology"},{"key":"2569_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.trsl.2022.03.005","volume":"245","author":"A Satyam","year":"2022","unstructured":"Satyam, A., R. Hisada, R. Bhargava, M.G. Tsokos, and G.C. Tsokos. 2022. Intertwined pathways of complement activation command the pathogenesis of lupus nephritis. Translational Research 245: 18\u201329.","journal-title":"Translational Research"},{"issue":"3","key":"2569_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.amjms.2017.01.005","volume":"353","author":"D Song","year":"2017","unstructured":"Song, D., W.Y. Guo, F.M. Wang, Y.Z. Li, Y. Song, F. Yu, et al. 2017. Complement alternative pathway\u05f3s activation in patients with lupus nephritis. American Journal of the Medical Sciences 353 (3): 247\u201357.","journal-title":"American Journal of the Medical Sciences"},{"issue":"7","key":"2569_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi, A., D. A. Rao, C. C. Berthier, A. Davidson, Y. Liu, and P. J. Hoover et al. 2019. The immune cell landscape in kidneys of patients with lupus nephritis. Nature Immunology 20(7):902\u2013914.","journal-title":"Nature Immunology"},{"issue":"7","key":"2569_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der, E., H. Suryawanshi, P. Morozov, M. Kustagi, B. Goilav, S. Ranabothu, et al. 2019. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nature Immunology 20 (7): 915\u201327.","journal-title":"Nature Immunology"},{"issue":"2","key":"2569_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening, J. J., V. D. D\u2019Agati, M. M. Schwartz, S. V. Seshan, C. E. Alpers, and G. B. Appel et al. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney International 65(2):521\u2013530.","journal-title":"Kidney International"},{"issue":"6","key":"2569_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41590-022-01200-7","volume":"23","author":"T Doke","year":"2022","unstructured":"Doke, T., A. Abedini, D. L. Aldridge, Y. W. Yang, J. Park, and C. M. Hernandez et al. 2022. Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis. Nature Immunology 23(6):947\u2013959.","journal-title":"Nature Immunology"},{"key":"2569_CR18","doi-asserted-by":"publisher","first-page":"1305590","DOI":"10.3389\/fimmu.2023.1305590","volume":"14","author":"YY Tang","year":"2023","unstructured":"Tang, Y. Y., D. C. Wang, Y. Y. Chen, W. D. Xu, and A. F. Huang. 2023. Th1-related transcription factors and cytokines in systemic lupus erythematosus. Frontiers in immunology 14:1305590.","journal-title":"Frontiers in immunology"},{"key":"2569_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annual Review Of Immunology 19:423\u2013474.","journal-title":"Annual Review Of Immunology"},{"issue":"6","key":"2569_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","volume":"25","author":"D Novick","year":"2013","unstructured":"Novick, D., S. Kim, G. Kaplanski, and C. A. Dinarello. 2013. Interleukin-18, more than a Th1 cytokine. Seminars In Immunology 25(6):439\u2013448.","journal-title":"Seminars In Immunology"},{"key":"2569_CR21","doi-asserted-by":"publisher","first-page":"955369","DOI":"10.3389\/fimmu.2023.955369","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang, X., L. Wang, X. Wen, L. Zhang, X. Jiang, and G. He. 2023. Interleukin-18 and IL-18BP in inflammatory dermatological diseases. Frontiers in immunology 14:955369.","journal-title":"Frontiers in immunology"},{"key":"2569_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413505","author":"D Novick","year":"2024","unstructured":"Novick, D. 2024. IL-18 and IL-18BP: A unique dyad in health and disease. International Journal of Molecular Sciences 25(24):13505. https:\/\/doi.org\/10.3390\/ijms252413505","journal-title":"International Journal of Molecular Sciences"},{"key":"2569_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030649","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K., K. Nakanishi, and H. Tsutsui. 2019. Interleukin-18 in health and disease. International Journal of Molecular Sciences 20(3):649. https:\/\/doi.org\/10.3390\/ijms20030649","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2569_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1468-3083.2003.00647.x","volume":"17","author":"S Gangemi","year":"2003","unstructured":"Gangemi, S., R. A. Merendino, F. Guarneri, P. L. Minciullo, G. DiLorenzo, and M. Pacor et al. 2003. Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations. Journal Of The European Academy Of Dermatology And Venereology 17(1):42\u201346.","journal-title":"Journal Of The European Academy Of Dermatology And Venereology"},{"issue":"3","key":"2569_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10067-004-0867-x","volume":"23","author":"MC Park","year":"2004","unstructured":"Park, M.C., Y.B. Park, and S.K. Lee. 2004. Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus. Clinical Rheumatology 23 (3): 225\u20139.","journal-title":"Clinical Rheumatology"},{"issue":"6","key":"2569_CR26","first-page":"1","volume":"17","author":"Z Rezaieyazdi","year":"2021","unstructured":"Rezaieyazdi, Z., M. AkbariRad, N. Saadati, M. Salari, R. Orang, and S. Sedighi et al. 2021. Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus. ARYA Atheroscler 17(6):1\u20136.","journal-title":"ARYA Atheroscler"},{"issue":"1","key":"2569_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10875-022-01353-y","volume":"43","author":"JE Rood","year":"2023","unstructured":"Rood, J. E., A. Rezk, J. Pogoriler, L. S. Finn, J. M. Burnham, and M. B. Josephson et al. 2023. Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1\u03b2 and IL-18. Journal Of Clinical Immunology 43(1):101\u2013108.","journal-title":"Journal Of Clinical Immunology"},{"key":"2569_CR28","doi-asserted-by":"publisher","first-page":"1486780","DOI":"10.3389\/fmed.2024.1486780","volume":"11","author":"S Thawanaphong","year":"2024","unstructured":"Thawanaphong, S., A. Nair, E. Volfson, P. Nair, and M. Mukherjee. 2024. IL-18 biology in severe asthma. Front Med (Lausanne) 11:1486780.","journal-title":"Front Med (Lausanne)"},{"key":"2569_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206058","author":"A Guha","year":"2024","unstructured":"Guha, A., R. Diaz-Pino, A. Fagbemi, S.M. Hughes, R.F. Wynn, G. Lopez-Castejon, et al. 2024. Very early-onset IBD-associated IL-18opathy treated with an anti-IL-18 antibody. Journal of Clinical Medicine 13(20):6058. https:\/\/doi.org\/10.3390\/jcm13206058","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"2569_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.57.2.342","volume":"57","author":"F Nicoletti","year":"2001","unstructured":"Nicoletti, F., R. Di Marco, K. Mangano, F. Patti, E. Reggio, and A. Nicoletti et al. 2001. Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology 57(2):342\u2013344.","journal-title":"Neurology"},{"issue":"3","key":"2569_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1034\/j.1600-0404.2001.00356.x","volume":"104","author":"J Losy","year":"2001","unstructured":"Losy, J., and A. Niezgoda. 2001. IL-18 in patients with multiple sclerosis. Acta Neurologica Scandinavica 104(3):171\u2013173.","journal-title":"Acta Neurologica Scandinavica"},{"key":"2569_CR32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3389\/fimmu.2018.01250","volume":"9","author":"R Mende","year":"2018","unstructured":"Mende, R., F. B. Vincent, R. Kandane-Rathnayake, R. Koelmeyer, E. Lin, and J. Chang et al. 2018. Analysis of Serum Interleukin (IL)-1\u03b2 and IL-18 in Systemic Lupus Erythematosus. Frontiers in immunology 9:1250.","journal-title":"Frontiers in immunology"},{"issue":"1","key":"2569_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2249.2004.02588.x","volume":"138","author":"N Calvani","year":"2004","unstructured":"Calvani, N., H. B. Richards, M. Tucci, G. Pannarale, and F. Silvestris. 2004. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clinical And Experimental Immunology 138(1):171\u2013178.","journal-title":"Clinical And Experimental Immunology"},{"issue":"4","key":"2569_CR34","first-page":"264","volume":"21","author":"P Migliorini","year":"2010","unstructured":"Migliorini, P., C. Anzilotti, F. Pratesi, P. Quattroni, M. Bargagna, and C. A. Dinarello et al. 2010. Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. European Cytokine Network 21(4):264\u2013271.","journal-title":"European Cytokine Network"},{"issue":"4","key":"2569_CR35","first-page":"303","volume":"3","author":"D Liang","year":"2006","unstructured":"Liang, D., W. Ma, C. Yao, H. Liu, and X. Chen. 2006. Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis. Cellular & Molecular Immunology 3(4):303\u2013306.","journal-title":"Cellular & Molecular Immunology"},{"key":"2569_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116369","volume":"226","author":"Y Qian","year":"2024","unstructured":"Qian, Y., N. Zhao, M. Wang, Z. Zou, and K. Xie. 2024. P2X7 receptor deficiency attenuates cisplatin-induced kidney injury via inhibiting NLRP3 inflammasome activation. Biochemical Pharmacology 226: 116369.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"2569_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2019.01.014","volume":"96","author":"SR Mulay","year":"2019","unstructured":"Mulay, S. R. 2019. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases. Kidney International 96(1):58\u201366.","journal-title":"Kidney International"},{"issue":"10","key":"2569_CR38","doi-asserted-by":"publisher","first-page":"e47417","DOI":"10.1371\/journal.pone.0047417","volume":"7","author":"EI Franke","year":"2012","unstructured":"Franke, E. I., B. A. Vanderbrink, K. L. Hile, H. Zhang, A. Cain, and F. Matsui et al. 2012. Renal IL-18 production is macrophage independent during obstructive injury. PloS one 7(10):e47417.","journal-title":"PloS one"},{"key":"2569_CR39","doi-asserted-by":"publisher","first-page":"108191","DOI":"10.1016\/j.pharmthera.2022.108191","volume":"239","author":"JM Thomas","year":"2022","unstructured":"Thomas, J. M., B. M. Huuskes, C. G. Sobey, G. R. Drummond, and A. Vinh. 2022. The IL-18\/IL-18R1 signalling axis: Diagnostic and therapeutic potential in hypertension and chronic kidney disease. Pharmacology & Therapeutics 239:108191.","journal-title":"Pharmacology & Therapeutics"},{"issue":"11","key":"2569_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41419-022-05394-4","volume":"13","author":"J Luan","year":"2022","unstructured":"Luan, J., J. Fu, C. Jiao, X. Hao, Z. Feng, and L. Zhu et al. 2022. IL-18 deficiency ameliorates the progression from AKI to CKD. Cell Death And Disease 13(11):957.","journal-title":"Cell Death And Disease"},{"key":"2569_CR41","doi-asserted-by":"publisher","first-page":"728417","DOI":"10.1155\/2012\/728417","volume":"2012","author":"B Shi","year":"2012","unstructured":"Shi, B., Z. Ni, L. Cao, M. Zhou, S. Mou, and Q. Wang et al. 2012. Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy. Mediators Inflamm 2012:728417.","journal-title":"Mediators Inflamm"},{"issue":"09","key":"2569_CR42","first-page":"696","volume":"49","author":"X Zhao","year":"2021","unstructured":"Zhao, X., J. Shi, and Y. Ma. 2021. Effect of hormone combined with mycophenolate mofetil and tacrolimus in treatment of lupus nephritis and effect on serum levels of IL-6, IL-13 and IL-18. Chinese Youjiang Medical Journal 49(09):696\u2013701.","journal-title":"Chinese Youjiang Medical Journal"},{"issue":"1","key":"2569_CR43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41467-024-44886-z","volume":"15","author":"C Cohen","year":"2024","unstructured":"Cohen, C., R. Mhaidly, H. Croizer, Y. Kieffer, R. Leclere, and A. Vincent-Salomon et al. 2024. WNT-dependent interaction between inflammatory fibroblasts and FOLR2\u2009+\u2009macrophages promotes fibrosis in chronic kidney disease. Nature Communications 15(1):743.","journal-title":"Nature Communications"},{"key":"2569_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031755","author":"TH Yeh","year":"2024","unstructured":"Yeh, T.H., K.C. Tu, H.Y. Wang, and J.Y. Chen. 2024. From acute to chronic: Unraveling the pathophysiological mechanisms of the progression from acute kidney injury to acute kidney disease to chronic kidney disease. International Journal of Molecular Sciences 25(3):1755. https:\/\/doi.org\/10.3390\/ijms25031755","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2569_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu, X., H. Que, Q. Li, and X. Wei. 2025. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Molecular Cancer 24(1):171.","journal-title":"Molecular Cancer"},{"issue":"6","key":"2569_CR46","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/fcp.13031","volume":"38","author":"S Saxena","year":"2024","unstructured":"Saxena, S., N. Dagar, V. Shelke, B. Puri, and A. B. Gaikwad. 2024. Wnt\/beta-catenin modulation: A promising frontier in chronic kidney disease management. Fundamental & Clinical Pharmacology 38(6):1020\u20131030.","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"4","key":"2569_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema, I.M., S. Wilhelmus, C.E. Alpers, J.A. Bruijn, R.B. Colvin, H.T. Cook, et al. 2018. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney International 93 (4): 789\u201396.","journal-title":"Kidney International"},{"key":"2569_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001220","author":"H Yang","year":"2024","unstructured":"Yang, H., H. Zhang, L. Tian, P. Guo, S. Liu, H. Chen, et al. 2024. Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K\/AKT\/NF-\u03baB signalling pathway. Lupus Science & Medicine 11:e001220. https:\/\/doi.org\/10.1136\/lupus-2024-001220","journal-title":"Lupus Science & Medicine"},{"key":"2569_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1749-6632.2009.04805.x","volume":"1173","author":"M Tucci","year":"2009","unstructured":"Tucci, M., S. Ciavarella, S. Strippoli, F. Dammacco, and F. Silvestris. 2009. Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review. Annals Of The New York Academy Of Sciences 1173:449\u2013457.","journal-title":"Annals Of The New York Academy Of Sciences"},{"issue":"1","key":"2569_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","volume":"20","author":"E Landy","year":"2024","unstructured":"Landy, E., H. Carol, A. Ring, and S. Canna. 2024. Biological and clinical roles of IL-18 in inflammatory diseases. Nature Reviews Rheumatology 20(1):33\u201347.","journal-title":"Nature Reviews Rheumatology"},{"issue":"3","key":"2569_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","volume":"43","author":"CR Parikh","year":"2004","unstructured":"Parikh, C.R., A. Jani, V.Y. Melnikov, S. Faubel, and C.L. Edelstein. 2004. Urinary interleukin-18 is a marker of human acute tubular necrosis. American Journal of Kidney Diseases 43 (3): 405\u201314.","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"2569_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40620-014-0113-9","volume":"28","author":"X Lin","year":"2015","unstructured":"Lin, X., J. Yuan, Y. Zhao, and Y. Zha. 2015. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. Journal Of Nephrology 28(1):7\u201316.","journal-title":"Journal Of Nephrology"},{"issue":"6","key":"2569_CR53","first-page":"777","volume":"22","author":"HF Liu","year":"2006","unstructured":"Liu, H. F., Y. Z. Xu, C. W. Yao, T. Chen, T. Hong, and D. Liang et al. 2006. [Evaluation of the relationship between IL-18 levels in urine and parameters of renal pathological changes in patients with lupus nephritis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22(6):777\u2013778.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"1","key":"2569_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2009030264","volume":"21","author":"IE Hall","year":"2010","unstructured":"Hall, I.E., S.G. Yarlagadda, S.G. Coca, Z. Wang, M. Doshi, P. Devarajan, et al. 2010. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Journal of the American Society of Nephrology 21 (1): 189\u201397.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"2569_CR55","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.120.16437","volume":"78","author":"JM Thomas","year":"2021","unstructured":"Thomas, J.M., Y.H. Ling, B. Huuskes, M. Jelinic, P. Sharma, N. Saini, et al. 2021. IL-18 (Interleukin-18) produced by renal tubular epithelial cells promotes renal inflammation and injury during deoxycorticosterone\/salt-induced hypertension in mice. Hypertension 78 (5): 1296\u2013309.","journal-title":"Hypertension"},{"issue":"2","key":"2569_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ki.2014.295","volume":"87","author":"Y Yang","year":"2015","unstructured":"Yang, Y., Z.X. Zhang, D. Lian, A. Haig, R.N. Bhattacharjee, and A.M. Jevnikar. 2015. IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney International 87 (2): 396\u2013408.","journal-title":"Kidney International"},{"issue":"8","key":"2569_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.autrev.2005.04.009","volume":"4","author":"N Calvani","year":"2005","unstructured":"Calvani, N., M. Tucci, H. B. Richards, P. Tartaglia, and F. Silvestris. 2005. Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4(8):542\u2013548.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"2569_CR58","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/art.10563","volume":"46","author":"J Faust","year":"2002","unstructured":"Faust, J., J. Menke, J. Kriegsmann, V. R. Kelley, W. J. Mayet, and P. R. Galle et al. 2002. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis And Rheumatism 46(11):3083\u20133095.","journal-title":"Arthritis And Rheumatism"},{"issue":"6","key":"2569_CR59","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H., and R. Nusse. 2012. Wnt\/\u03b2-catenin signaling and disease. Cell 149 (6): 1192\u2013205.","journal-title":"Cell"},{"issue":"1","key":"2569_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00018-023-05068-0","volume":"81","author":"D Zhang","year":"2024","unstructured":"Zhang, D., Q. Q. Ni, S. Y. Wang, W. F. He, Z. X. Hong, and H. Y. Liu et al. 2024. APC mutations disrupt \u03b2-catenin destruction complex condensates organized by Axin phase separation. Cellular And Molecular Life Sciences 81(1):57.","journal-title":"Cellular And Molecular Life Sciences"},{"issue":"852","key":"2569_CR61","doi-asserted-by":"publisher","first-page":"eado0881","DOI":"10.1126\/scisignal.ado0881","volume":"17","author":"MD Enos","year":"2024","unstructured":"Enos, M. D., M. Gavagan, N. Jameson, J. G. Zalatan, and W. I. Weis. 2024. Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3\u03b2. Science Signaling 17(852):eado0881.","journal-title":"Science Signaling"},{"issue":"4","key":"2569_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104159","volume":"25","author":"SM Law","year":"2022","unstructured":"Law, S.M., and J.J. Zheng. 2022. Premise and peril of Wnt signaling activation through GSK-3\u03b2 inhibition. iScience 25 (4): 104159.","journal-title":"iScience"},{"key":"2569_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051112","author":"JK Min","year":"2022","unstructured":"Min, J.K., H.S. Park, Y.B. Lee, J.G. Kim, J.I. Kim, and J.B. Park. 2022. Cross-talk between Wnt signaling and Src tyrosine kinase. Biomedicines 10(5):1112. https:\/\/doi.org\/10.3390\/biomedicines10051112","journal-title":"Biomedicines"},{"issue":"1","key":"2569_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59899-z","volume":"10","author":"TW Parker","year":"2020","unstructured":"Parker, T.W., and K.L. Neufeld. 2020. APC controls Wnt-induced \u03b2-catenin destruction complex recruitment in human colonocytes. Scientific Reports 10 (1): 2957.","journal-title":"Scientific Reports"},{"issue":"3","key":"2569_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","volume":"17","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S. J., J. Floege, D. Fliser, and T. Speer. 2021. WNT-\u03b2-catenin signalling - a versatile player in kidney injury and repair. Nature Reviews Nephrology 17(3):172\u2013184.","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"2569_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084852","volume":"9","author":"XD Wang","year":"2014","unstructured":"Wang, X.D., X.F. Huang, Q.R. Yan, and C.D. Bao. 2014. Aberrant activation of the WNT\/\u03b2-catenin signaling pathway in lupus nephritis. PLoS One 9 (1): e84852.","journal-title":"PLoS One"},{"key":"2569_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00784","volume":"10","author":"D Fu","year":"2019","unstructured":"Fu, D., S. Senouthai, J. Wang, and Y. You. 2019. FKN facilitates HK-2 cell EMT and tubulointerstitial lesions via the Wnt\/\u03b2-catenin pathway in a murine model of lupus nephritis. Frontiers in Immunology 10: 784.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2569_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semnephrol.2020.01.004","volume":"40","author":"T Huffstater","year":"2020","unstructured":"Huffstater, T., W. D. Merryman, and L. S. Gewin. 2020. Wnt\/\u03b2-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease. Seminars In Nephrology 40(2):126\u2013137.","journal-title":"Seminars In Nephrology"},{"issue":"66","key":"2569_CR69","doi-asserted-by":"publisher","first-page":"109962","DOI":"10.18632\/oncotarget.20584","volume":"8","author":"J Bao","year":"2017","unstructured":"Bao, J., C. Ma, J. Ran, Y. Xiong, S. Yan, and L. Wu. 2017. Wnt\/\u03b2-catenin and hedgehog pathways are involved in the inflammatory effect of interleukin 18 on rat chondrocytes. Oncotarget 8 (66): 109962\u201372.","journal-title":"Oncotarget"},{"issue":"12","key":"2569_CR70","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1002\/jcp.22676","volume":"226","author":"VS Reddy","year":"2011","unstructured":"Reddy, V. S., A. J. Valente, P. Delafontaine, and B. Chandrasekar. 2011. Interleukin-18\/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation. Journal Of Cellular Physiology 226(12):3303\u20133315.","journal-title":"Journal Of Cellular Physiology"},{"issue":"12","key":"2569_CR71","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/2211-5463.12532","volume":"8","author":"Y Li","year":"2018","unstructured":"Li, Y., Z. Xu, J. Li, S. Ban, C. Duan, and W. Liu. 2018. Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts. FEBS Open Bio 8(12):1953\u20131963.","journal-title":"FEBS Open Bio"},{"issue":"3","key":"2569_CR72","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"BC Liu","year":"2018","unstructured":"Liu, B. C., T. T. Tang, L. L. Lv, and H. Y. Lan. 2018. Renal tubule injury: a driving force toward chronic kidney disease. Kidney International 93(3):568\u2013579.","journal-title":"Kidney International"},{"issue":"15","key":"2569_CR73","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1042\/CS20210447","volume":"135","author":"W Gong","year":"2021","unstructured":"Gong, W., C. Luo, F. Peng, J. Xiao, Y. Zeng, B. Yin, et al. 2021. Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt\/\u03b2-catenin\/autophagy axis. Clinical Science (London, England\u202f: 1979) 135 (15): 1873\u201395.","journal-title":"Clinical Science (London, England : 1979)"},{"issue":"4","key":"2569_CR74","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2017050574","volume":"29","author":"C Luo","year":"2018","unstructured":"Luo, C., S. Zhou, Z. Zhou, Y. Liu, L. Yang, and J. Liu et al. 2018. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells. Journal Of The American Society Of Nephrology 29(4):1238\u20131256.","journal-title":"Journal Of The American Society Of Nephrology"},{"issue":"5","key":"2569_CR75","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0955-0674(97)80122-6","volume":"9","author":"AI Barth","year":"1997","unstructured":"Barth, A.I., I.S. N\u00e4thke, and W.J. Nelson. 1997. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Current Opinion in Cell Biology 9 (5): 683\u201390.","journal-title":"Current Opinion in Cell Biology"},{"issue":"26","key":"2569_CR76","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1073\/pnas.262663399","volume":"99","author":"V Hurgin","year":"2002","unstructured":"Hurgin, V., D. Novick, and M. Rubinstein. 2002. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta. Proc Natl Acad Sci U S A 99(26):16957\u201316962.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2569_CR77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64498","author":"G Ambrosi","year":"2022","unstructured":"Ambrosi, G., O. Voloshanenko, A.F. Eckert, D. Kranz, G.U. Nienhaus, and M. Boutros. 2022. Allele-specific endogenous tagging and quantitative analysis of \u03b2-catenin in colorectal cancer cells. eLife 11:e64498. https:\/\/doi.org\/10.7554\/eLife.64498","journal-title":"eLife"},{"key":"2569_CR78","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fncel.2014.00214","volume":"8","author":"EM Sutinen","year":"2014","unstructured":"Sutinen, E. M., M. A. Korolainen, J. H\u00e4yrinen, I. Alafuzoff, S. Petratos, and A. Salminen et al. 2014. Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Frontiers In Cellular Neuroscience 8:214.","journal-title":"Frontiers In Cellular Neuroscience"},{"issue":"3","key":"2569_CR79","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3892\/or.2015.3724","volume":"33","author":"W Liu","year":"2015","unstructured":"Liu, W., M. Hu, Y. Wang, B. Sun, Y. Guo, and Z. Xu et al. 2015. Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3\u03b2 signaling. Oncology Reports 33(3):1049\u20131056.","journal-title":"Oncology Reports"},{"issue":"1","key":"2569_CR80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue, W., L. Yang, C. Chen, M. Ashrafizadeh, Y. Tian, and R. Sun. 2024. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cellular And Molecular Life Sciences 81(1):79.","journal-title":"Cellular And Molecular Life Sciences"},{"issue":"12","key":"2569_CR81","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.cellsig.2008.09.001","volume":"20","author":"M Soda","year":"2008","unstructured":"Soda, M., K. Willert, K. Kaushansky, and A. E. Geddis. 2008. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway. Cellular Signalling 20(12):2317\u20132323.","journal-title":"Cellular Signalling"},{"issue":"11","key":"2569_CR82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.urolonc.2015.05.006","volume":"33","author":"B Li","year":"2015","unstructured":"Li, B., J. B. Thrasher, and P. Terranova. 2015. Glycogen synthase kinase-3: a potential preventive target for prostate cancer management. Urologic Oncology 33(11):456\u2013463.","journal-title":"Urologic Oncology"},{"issue":"10","key":"2569_CR83","first-page":"3928","volume":"12","author":"X Pan","year":"2019","unstructured":"Pan, X., L. Ma, and J. Wang. 2019. Correlation between CK1\u03b1 and \u03b2-catenin Ser45-phosphorylation in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 12(10):3928\u20133933.","journal-title":"Int J Clin Exp Pathol"},{"key":"2569_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ceb.2014.08.003","volume":"31","author":"CM Cruciat","year":"2014","unstructured":"Cruciat, C. M. 2014. Casein kinase 1 and Wnt\/\u03b2-catenin signaling. Current Opinion In Cell Biology 31:46\u201355.","journal-title":"Current Opinion In Cell Biology"},{"issue":"1","key":"2569_CR85","doi-asserted-by":"publisher","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos, J. L., and W. I. Weis. 2013. The \u03b2-catenin destruction complex. Cold Spring Harbor Perspectives In Biology 5(1):a007898.","journal-title":"Cold Spring Harbor Perspectives In Biology"},{"issue":"7020","key":"2569_CR86","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nature03179","volume":"432","author":"J Jia","year":"2004","unstructured":"Jia, J., C. Tong, B. Wang, L. Luo, and J. Jiang. 2004. Hedgehog signalling activity of Smoothened requires phosphorylation by protein kinase A and casein kinase I. Nature 432 (7020): 1045\u201350.","journal-title":"Nature"},{"issue":"23","key":"2569_CR87","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1042\/BCJ20200506","volume":"477","author":"LJ Fulcher","year":"2020","unstructured":"Fulcher, L. J., and G. P. Sapkota. 2020. Functions and regulation of the serine\/threonine protein kinase CK1 family: moving beyond promiscuity. The Biochemical Journal 477(23):4603\u20134621.","journal-title":"The Biochemical Journal"},{"key":"2569_CR88","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/bs.ctdb.2016.09.002","volume":"123","author":"J Jiang","year":"2017","unstructured":"Jiang, J. 2017. CK1 in Developmental Signaling: Hedgehog and Wnt. Current Topics In Developmental Biology 123:303\u2013329.","journal-title":"Current Topics In Developmental Biology"},{"issue":"6","key":"2569_CR89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212255120","volume":"120","author":"J Park","year":"2023","unstructured":"Park, J., K. Lee, H. Kim, H. Shin, and C. Lee. 2023. Endogenous circadian reporters reveal functional differences of PERIOD paralogs and the significance of PERIOD:CK1 stable interaction. Proceedings of the National Academy of Sciences of the United States of America 120 (6): e2212255120.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1 Pt 1","key":"2569_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","volume":"103","author":"CA Dinarello","year":"1999","unstructured":"Dinarello, C. A. 1999. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. The Journal Of Allergy And Clinical Immunology 103(1 Pt 1):11\u201324.","journal-title":"The Journal Of Allergy And Clinical Immunology"},{"key":"2569_CR91","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","volume":"9","author":"K Nakanishi","year":"2018","unstructured":"Nakanishi, K. 2018. Unique Action of Interleukin-18 on T Cells and Other Immune Cells. Frontiers in immunology 9:763.","journal-title":"Frontiers in immunology"},{"issue":"6","key":"2569_CR92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.moh.0000141926.95319.42","volume":"11","author":"P Reddy","year":"2004","unstructured":"Reddy, P. 2004. Interleukin-18: recent advances. Current Opinion In Hematology 11(6):405\u2013410.","journal-title":"Current Opinion In Hematology"},{"issue":"6","key":"2569_CR93","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1080\/14397595.2016.1270387","volume":"27","author":"L Zhang","year":"2017","unstructured":"Zhang, L., H. Zhu, Y. Li, X. Dai, B. Zhou, and Q. Li et al. 2017. The role of IFI35 in lupus nephritis and related mechanisms. Modern Rheumatology 27(6):1010\u20131018.","journal-title":"Modern Rheumatology"},{"issue":"8","key":"2569_CR94","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.4049\/jimmunol.160.8.3713","volume":"160","author":"C Haas","year":"1998","unstructured":"Haas, C., B. Ryffel, and M. Le Hir. 1998. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. The Journal Of Immunology 160(8):3713\u20133718.","journal-title":"The Journal Of Immunology"},{"issue":"3","key":"2569_CR95","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/03009740500417791","volume":"35","author":"P Enghard","year":"2006","unstructured":"Enghard, P., D. Langnickel, and G. Riemekasten. 2006. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB\/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scandinavian Journal Of Rheumatology 35(3):209\u2013216.","journal-title":"Scandinavian Journal Of Rheumatology"},{"issue":"8","key":"2569_CR96","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41374-022-00777-9","volume":"102","author":"B Wang","year":"2022","unstructured":"Wang, B., X. Jiang, Y. Li, H. Xu, B. Ying, and J. Qiu et al. 2022. YY1 alleviates lupus nephritis-induced renal injury by reducing the Th17\/Treg cell ratio via the IFN-\u03b3\/Fra2 axis. Laboratory Investigation 102(8):872\u2013884.","journal-title":"Laboratory Investigation"},{"key":"2569_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010063","author":"HR Bae","year":"2024","unstructured":"Bae, H.R., S.K. Shin, J.Y. Lee, Y.J. Ko, S. Kim, H.A. Young, et al. 2024. Chronic low-level IFN-\u03b3 expression disrupts mitochondrial complex I activity in renal macrophages: An early mechanistic driver of lupus nephritis pathogenesis. International Journal of Molecular Sciences 26(1):63. https:\/\/doi.org\/10.3390\/ijms26010063","journal-title":"International Journal of Molecular Sciences"},{"key":"2569_CR98","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O\u2019Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review Of Immunology 19:683\u2013765.","journal-title":"Annual Review Of Immunology"},{"issue":"2","key":"2569_CR99","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1084\/jem.2042fta","volume":"204","author":"H Bashyam","year":"2007","unstructured":"Bashyam, H. 2007. Th1\/Th2 cross-regulation and the discovery of IL-10. Journal Of Experimental Medicine 204(2):237.","journal-title":"Journal Of Experimental Medicine"},{"issue":"1","key":"2569_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00296-010-1609-9","volume":"32","author":"X Liu","year":"2012","unstructured":"Liu, X., C. Bao, and D. Hu. 2012. Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis. Rheumatology International 32(1):223\u2013229.","journal-title":"Rheumatology International"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:41Z","timestamp":1791475421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02569-5","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University (approval No. 2023\u2009\u2212\u2009345), and written informed consent was obtained from every participant before specimen collection. And the protocol was also approved by the Animal Ethics Committee of Guizhou Medical University (approval No. 2304903) and complied with international guidelines for laboratory animal welfare.","order":1,"name":"Ethics","label":"Ethical approval and consent to participant","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"196"}}